Enodia Therapeutics Appoints Dr. Yvonne McGrath as Chief Scientific Officer to Accelerate Upstream Targeted Protein Degradation Platform
Immunocore (IMCR) had its "buy" rating reaffirmed by HC Wainwright. They now have a $100.00 price target on the stock.
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
A Look At Immunocore (IMCR) Valuation After Jefferies Downgrade And Kimmtrak Growth Concerns [Yahoo! Finance]
Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer [Yahoo! Finance]